Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...
COVID-19 vaccination mandates and requirements can be effective in increasing vaccination rates, but their success depends on being targeted and on building trust, says a new rapid expert consultation ...
Moderna (NASDAQ:MRNA) draws focus after a flu-vaccine approval, adding to an active session across the healthcare sector.